Schedule dependency of anticancer effect of 1-beta-D-arabinofuranosylcytosine on rat ascites hepatomas.
D000818:Animals; D003561:Cytarabine / Q000008:administration & dosage* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D008114:Liver Neoplasms, Experimental / Q000188:drug therapy*; D008297:Male; D051381:Rats
D003561:Cytarabine